News
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...
And other biotech news brought to you by The Readout.
3h
Zacks.com on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?LLY's blockbuster obesity drugs fuel rapid growth but ABBV's valuation and pipeline may offer safer short-term upside.
Jim Rogers, 58, was living and working in Australia when he started to develop symptoms of the incurable neurological ...
TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...
Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...
Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...
And more pharma news updates from Pharmalittle.
1h
GB News on MSNBriton, 58, says partner and colleagues noticed troubling dementia sign 'years' before diagnosisA routine medical appointment revealed the first sign of early-onset dementia for Jim Rogers, a 58-year-old British man ...
The UK's state-run health service said Thursday it will not offer two new treatments for Alzheimer's disease, citing high ...
NEW YORK – The UK's National Institute for Health and Care Excellence on Thursday issued two final guidances, in which it recommended against making Eisai and Biogen's Leqembi (lecanemab) and Eli ...
Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results